# Coherus BioSciences (United States)

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/coherus-biosciences-united-states/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 68.7 |
| Citations | 13,698 |
| City | Redwood City |
| Country | US |
| Description | Coherus BioSciences (United States) is a research organisation in Redwood City, US. OpenAlex records 288 works and 13,698 citations for it. 164 researchers list it as their most recent affiliation. |
| Homepage | http://www.coherus.com/ |
| OpenAlex ID | https://openalex.org/I4210100603 |
| Region | California |
| Researchers | 164 |
| ROR ID | https://ror.org/00mjj2d85 |
| Type | company |
| Works | 288 |

## University papers

Showing 12 of 19.

- [Chronic Health Conditions in Adult Survivors of Childhood Cancer](https://scholariq.org/papers/chronic-health-conditions-in-adult-survivors-of-childhood-cancer/)
- [Estimates of global seasonal influenza-associated respiratory mortality: a modelling study](https://scholariq.org/papers/estimates-of-global-seasonal-influenza-associated-respiratory-mortality-a/)
- [Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort](https://scholariq.org/papers/survival-and-prognosis-with-osteosarcoma-outcomes-in-more-than-2000-patients-in/)
- [Development of Risk-Based Guidelines for Pediatric Cancer Survivors: The Children's Oncology Group Long-Term Follow-Up Guidelines From the Children's Oncology Group Late Effects Committee and Nursing Discipline](https://scholariq.org/papers/development-of-risk-based-guidelines-for-pediatric-cancer-survivors-the-children/)
- [Biology and Therapeutic Advances for Pediatric Osteosarcoma](https://scholariq.org/papers/biology-and-therapeutic-advances-for-pediatric-osteosarcoma/)
- [Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial](https://scholariq.org/papers/comparison-of-mapie-versus-map-in-patients-with-a-poor-response-to-preoperative/)
- [Successful Elimination of Covid-19 Transmission in New Zealand](https://scholariq.org/papers/successful-elimination-of-covid-19-transmission-in-new-zealand/)
- [Genome-Informed Targeted Therapy for Osteosarcoma](https://scholariq.org/papers/genome-informed-targeted-therapy-for-osteosarcoma/)
- [Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial](https://scholariq.org/papers/methotrexate-doxorubicin-and-cisplatin-map-plus-maintenance-pegylated-interferon/)
- [Abnormalities of the Thyroid in Survivors of Hodgkin’s Disease: Data from the Childhood Cancer Survivor Study<sup>1</sup>](https://scholariq.org/papers/abnormalities-of-the-thyroid-in-survivors-of-hodgkin-s-disease-data-from-the/)
- [EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment](https://scholariq.org/papers/euramos-1-an-international-randomised-study-for-osteosarcoma-results-from-pre/)
- [Dose-Intensified Compared With Standard Chemotherapy for Nonmetastatic Ewing Sarcoma Family of Tumors: A Children's Oncology Group Study](https://scholariq.org/papers/dose-intensified-compared-with-standard-chemotherapy-for-nonmetastatic-ewing/)

## University researchers

- [Neyssa Marina](https://scholariq.org/researchers/neyssa-marina/)

## University top topics

Showing 8 of 25.

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Prostate Cancer Diagnosis and Treatment](https://scholariq.org/topics/prostate-cancer-diagnosis-and-treatment/)
- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.